Clinical Trial Update: CEST-based Biomarkers to Delineate the Epileptogenic Zone [NA]

View source ↗

Summary

This study investigates CEST-based MRI biomarkers to delineate the epileptogenic zone in treatment-refractory epilepsy; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Epilepsy (Treatment Refractory) | NA | Status: NOT_YET_RECRUITING